Small bowel adenocarcinoma: A rare but aggressive disease

Clinical Colorectal Cancer

Volumn 4, Issue 4, 2004, Pages 241-248

  Delaunoit, Thierry ^a   Neczyporenko, Florence ^a   Limburg, Paul J ^a   Erlichman, Charles ^a  

^a MAYO CLINIC   (United States)

Author keywords

Drug therapy; Endoscopy; Intestinal neoplasms; Small intestine

Indexed keywords

BARIUM; CISPLATIN; ENEMA; EPIRUBICIN; FLUOROURACIL; IRINOTECAN; METHOTREXATE; OXALIPLATIN;

ADENOCARCINOMA; BARIUM ENEMA; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; CLINICAL TRIAL; COLON; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIGESTIVE SYSTEM TUMOR; DRUG EFFICACY; ECHOGRAPHY; FATALITY; HISTOPATHOLOGY; HUMAN; INTESTINE ENDOSCOPY; INTESTINE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATICODUODENECTOMY; PATHOGENESIS; PROGNOSIS; RECTUM; REVIEW; SENSITIVITY ANALYSIS; SMALL INTESTINE CARCINOMA; SURGICAL TECHNIQUE; TREATMENT PLANNING;

EID: 10944232677     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2004.n.023     Document Type: Review

References (84)

1. Abrahams NA, Halverson A, Fazio VW, et al. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 2002; 45:1496-1502.
2. Ashley SW, Wells SA Jr. Tumors of the small intestine. Semin Oncol 1988; 15:116-128.
3. Howe JR, Karnell LH, Menck HR, et al. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1999; 86:2693-2706.
4. Weiss NS, Yang CP. Incidence of histologic types of cancer of the small intestine. J Natl Cancer Inst 1987; 78:653-656.
5. Brucher BL, Stein HJ, Roder JD, et al. New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology 2001; 48:727-732.
6. Gill SS, Heuman DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol 2001; 33:267-282.
7. Lewis JD, Deren JJ, Lichtenstein GR, Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28:459-477.
8. Kenwright S. Coeliac disease and small bowel carcinoma. Postgrad Med J 1972; 48:673-677.
9. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119:1447-1453.
10. Spigelman AD, Williams CB, Talbot IC, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2:783-785.
11. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110:1020-1027.
12. Crawley C, Ross P, Norman A, et al. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil. Br J Cancer 1998; 78:508-510.
13. Jigyasu D, Bedikian AY, Stroehlein JR. Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 1984; 53:23-25.
14. Coia L, Hoffman J, Scher R, et al. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 1994; 30:161-167.
15. Yeung RS, Weese JL, Hoffman JP, et al. Ncoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study. Cancer 1993; 72:2124-2133.
16. Sohn TA, Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 1998; 2:79-87.
17. Michelassi F, Testa G, Pomidor WJ, et al. Adenocarcinoma complicating Crohn's disease. Dis Colon Rectum 1993; 36:654-661.
18. Hawker PC, Gyde SN, Thompson H, et al, Adenocarcinoma of the small intestine complicating Crohn's disease. Gut 1982; 23:188-193.
19. Lynch HT, Smyrk TC, Lynch PM, et al. Adenocarcinoma of the small bowel in lynch syndrome II. Cancer 1989; 64:2178-2183.
20. Rodriguez-Bigas MA, Vasen HF, Lynch HT, et al. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer 1998; 83:240-244.
21. Sellner F. Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 1990; 66:702-715.
22. Talamonti MS, Goetz LH, Rao S, et al. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg 2002; 137:564-570.
23. Severson RK, Schenk M, Gurney JG, et al. Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults. Cancer Epidemiol Biomarkers Prev 1996; 5:81-84.
24. Cunningham JD, Aleali R, Aleali M, et al. Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival. Ann Surg 1997; 225:300-306.
25. Kaerlev L, Teglbjaerg PS, Sabroe S, et al. Medical risk factors for small-bowel adenocarcinoma with focus on Crohn disease: a European population-based case-control study. Scand J Gastroenterol 2001; 36:641-646.
26. Ojha A, Zacherl J, Scheuba C, et al, Primary small bowel malignancies: single-center results of three decades. J Clin Gastroenterol 2000; 30:289-293.
27. Hutchins RR, Bani Hani A, Kojodjojo P, et al. Adenocarcinoma of the small bowel. Aust N Z J Surg 2001; 71:428-437.
28. Maglinte DD, O'Connor K, Bessette J, et al. The role of the physician in the late diagnosis of primary malignant tumors of the small intestine. Am J Gastroenterol 1991; 86:304-308.
29. Onuma. EK, Amenta PS, Jukkola AF, et al., A phenotypic change of small intestinal epithelium to colonocytes in small intestinal adenomas and adenocarcinomas. Am J Gastroenterol 2001; 96:2480-2485.
30. Small Intestine. In: American Joint Committee on Cancer. AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1997:77-81.
31. Arber N, Hibshoosh H, Yasui W, et al. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. Cancer Epidemiol Biomarkers Prev 1999; 8:1101-1105.
32. Sutter T, Arber N, Moss SF, et al. Frequent K-ras mutations in small bowel adenocarcinomas. Dig Dis Sci 1996; 41:115-118.
33. Younes N, Fulton N, Tanaka R, et al. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Cancer 1997; 79:1804-1808.
34. Svrcek M, Jourdan F, Sebbagh N, et al. Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study. J Clin Pathol 2003; 56:898-903.
35. Wheeler JM, Warren BF, Mortensen NJ, et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 2002; 50:218-223.
36. Bessette JR, Maglinte DD, Kelvin FM, et al. Primary malignant tumors in the small bowel: a comparison of the small-bowel enema and conventional follow-through examination. AJR Am J Roentgenol 1989; 153:741-744.
37. Maccioni F, Rossi P, Gourtsoyiannis N, et al. US and CT findings of small bowel neoplasms. Eur Radiol 1997; 7:1398-1409.
38. Bruneton JN, Drouillard J, Bourry J, et al., Adenocarcinoma of the small intestine. Current state of diagnosis and treatment. A study of 27 cases and a review of the literature. J Radiol 1983; 64:117-123.
39. Levine MS, Drooz AT, Herlinger H. Annular malignancies of the small bowel. Gastrointest Radiol 1987; 12:53-58.
40. Ekberg O, Ekholm S. Radiology in primary small bowel adenocarcinoma. Gastrointest Radiol 1980; 5:49-53.
41. Gourtsoyiannis N, Mako E. Imaging of primary small intestinal tumours by enteroclysis and CT with pathological correlation. Eur Radiol 1997; 7:625-642.
42. Buckley JA, Siegelman SS, Jones B, et al. The accuracy of CT staging of small bowel adenocarcinoma: CT/pathologic correlation. J Comput Assist Tomogr 1997; 21:986-991.
43. Laurent F, Raynaud M, Biset JM, et al. Diagnosis and categorization of small bowel neoplasms: role of computed tomography. Gastrointest Radiol 1991; 16:115-119.
44. Maglinte DD, Bender GN, Heitkamp DE, et al. Multidetector-row helical CT enteroclysis. Radiol Clin North Am 2003; 41:249-262.
45. Debatin JF, Patak MA. MRI of the small and large bowel. Eur Radiol 1999; 9:1523-1534.
46. Kim JH, Ha HK, Sohn MJ, et al. Usefulness of MR imaging for diseases of the small intestine: comparison with CT. Korean J Radiol 2000; 1:43-50.
47. Umschaden HW, Gasser J. MR enteroclysis. Radiol Clin North Am 2003; 41:231-248.
48. Rossini FP, Risio M, Pennazio M. Small bowel tumors and polyposis syndromes. Gastrointest Endosc Clin N Am 1999; 9:93-114.
49. Gay GJ, Delmotte JS. Enteroscopy in small intestinal inflammatory diseases. Gastrointest Endosc Clin N Am 1999; 9:115-123.
50. Chen RY, Taylor AC, Desmond PV. Push enteroscopy: a single centre experience and review of published series. Aust N Z J Surg 2002; 72:215-218.
51. Soderman C, Uribe A. Enteroscopy as a tool for diagnosing gastrointestinal bleeding requiring blood transfusion. Surg Laparosc Endosc Percutan Tech 2001; 11:97-102.
52. Shackel NA, Bowen DG, Selby WS. Video push enteroscopy in the investigation of small bowel disease: defining clinical indications and outcomes. Aust N Z J Med 1998; 28:198-203.
53. Bouhnik Y, Bitoun A, Coffin B, et al. Two way push videoenteroscopy in investigation of small bowel disease. Gut 1998; 43:280-284.
54. Swain CP. The role of enteroscopy in clinical practice. Gastrointest Endosc Clin N Am 1999; 9:135-144.
55. Swain P. Wireless capsule endoscopy. Gut 2003; 52(suppl 4):iv48-iv50.
56. Scapa E, Jacob H, Lewkowicz S, et al. Initial experience of wireless-capsule endoscopy for evaluating occult gastrointestinal bleeding and suspected small bowel pathology. Am J Gastroenterol 2002; 97:2776-2779.
57. Ell C, Remke S, May A, et al. The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding. Endoscopy 2002; 34:685-689.
58. Mylonaki M, Fritscher-Ravens A, Swain P. Wireless capsule endoscopy: a comparison with push enteroscopy in patients with gastroscopy and colonoscopy negative gastrointestinal bleeding. Gut 2003; 52:1122-1126.
59. Gasche C, Moser G, Turetschek K, et al. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut 1999; 44:112-117.
60. Parente F, Maconi G, Bollani S, et al. Bowel ultrasound in assessment of Crohn's disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings. Gut 2002; 50:490-495.
61. Kalady MF, Clary BM, Clark LA, et al. Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. Ann Surg Oncol 2002; 9:799-806.
62. Enns R. Acute lower gastrointestinal bleeding: part 1. Can J Gastroenterol 2001; 15:509-516.
63. DiSario JA, Burt RW, Vargas H, et al. Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol 1994; 89:699-701.
64. Adler SN, Lyon DT, Sullivan PD. Adenocarcinoma of the small bowel. Clinical features, similarity to regional enteritis, and analysis of 338 documented cases. Am J Gastroenterol 1982; 77:326-330.
65. Desa LA, Bridger J, Grace PA, et al. Primary jejunoileal tumors: a review of 45 cases. World J Surg 1991; 15:81-86.
66. Norberg KA, Emas S. Primary tumors of the small intestine. Am J Surg 1981; 142:569-573.
67. Veyrieres M, Baillet P, Hay JM, et al. Factors influencing long-term survival in 100 cases of small intestine primary adenocarcinoma. Am J Surg 1997; 173:237-239.
68. Kaklamanos IG, Bathe OF, Franceschi D, et al. Extent of resection in the management of duodenal adenocarcinoma. Am J Surg 2000; 179:37-41.
69. Hirasawa R, Iishi H, Tatsuta M, et al. Clinicopathologic features and endoscopic resection of duodenal adenocarcinomas and adenomas with the submucosal saline injection technique. Gastrointest Endosc 1997; 46:507-513.
70. Webber J, Herman M, Kessel D, et al. Photodynamic treatment of neoplastic lesions of the gastrointestinal tract. Recent advances in techniques and results. Langenbecks Arch Surg 2000; 385:299-304.
71. Norton ID, Geller A, Petersen BT, et al. Endoscopic surveillance and ablative therapy for periampullary adenomas. Am J Gastroenterol 2001; 96:101-106.
72. Tocchi A, Mazzoni G, Puma F, et al. Adenocarcinoma of the third and fourth portions of the duodenum: results of surgical treatment. Arch Surg 2003; 138:80-85.
73. Jacobs PP, van der Sluis RF, Wobbes T. Role of gastroenterostomy in the palliative surgical treatment of pancreatic cancer. J Surg Oncol 1989; 42:145-149.
74. Mauro MA, Koehler RE, Baron TH. Advances in gastrointestinal intervention: the treatment of gastroduodenal and colorectal obstructions with metallic stents. Radiology 2000; 215:659-669.
75. Feretis C, Benakis P, Dimopoulos C, et al. Duodenal obstruction caused by pancreatic head carcinoma: palliation with self-expandable endoprostheses. Gastrointest Endosc 1997; 46:161-165.
76. Jung GS, Song HY, Kang SG, et al. Malignant gastroduodenal obstructions: treatment by means of a covered expandable metallic stent - initial experience. Radiology 2000; 216:758-763.
77. Singh S, Gagneja HK. Stents in the small intestine. Curr Gastroenterol Rep 2002; 4:383-391.
78. Laurent C, Rullier E, Feyler A, et al. Resection of noncolorectal and nonneuroendocrine liver metastases: late metastases are the only chance of cure. World J Surg 2001; 25:1532-1536.
79. Goering JD, Mahvi DM, Niederhuber JE, et al. Cryoablation and liver resection for noncolorectal liver metastases. Am J Surg 2002; 183:384-389.
80. Karavias DD, Tepetes K, Karatzas T, et al. Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms. Eur J Surg Oncol 2002; 28:135-139.
81. Benevento A, Boni L, Frediani L, et al. Result of liver resection as treatment for metastases from noncolorectal cancer. J Surg Oncol 2000; 74:24-29.
82. Hemming AW, Sielaff TD, Gallinger S, et al. Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl 2000; 6:97-101.
83. Onodera H, Nishitai R, Shimizu K, et al. Small intestinal cancer with extensive lymph node metastases showing complete remission by methotrexate/5-fluorouracil sequential therapy: report of a case. Surg Today 1997; 27:60-63.
84. Erlichman C, Goldberg R, Sloan J, et al. Phase I study of the combination of CPT-11/5FU/leucovorin/oxaliplatin. Proc Am Soc Clin Oncol 2002; 21:107a (Abstract #426).